{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.196.11.1527","meta":{"versionId":"16","lastUpdated":"2021-02-20T01:03:49.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1527","version":"20210220","name":"Scopolamine","status":"active","date":"2021-02-20T01:03:49-05:00","publisher":"NCQA PHEMUR","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"1046787","display":"atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML Oral Solution"},{"code":"1046815","display":"atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG Oral Tablet"},{"code":"1046997","display":"atropine sulfate 0.0582 MG / hyoscyamine sulfate 0.311 MG / phenobarbital 48.6 MG / scopolamine hydrobromide 0.0195 MG Extended Release Oral Tablet"},{"code":"1048124","display":"12 HR atropine sulfate 0.04 MG / chlorpheniramine maleate 8 MG / hyoscyamine sulfate 0.19 MG / pseudoephedrine hydrochloride 90 MG / scopolamine hydrobromide 0.01 MG Extended Release Oral Tablet"},{"code":"1048147","display":"atropine sulfate 0.0582 MG / hyoscyamine sulfate 0.3111 MG / phenobarbital 48.6 MG / scopolamine hydrobromide 0.0195 MG Extended Release Oral Tablet"},{"code":"198207","display":"scopolamine 0.4 MG/ML Injectable Solution"},{"code":"226552","display":"72 HR scopolamine 0.0139 MG/HR Transdermal System"}]}]},"expansion":{"identifier":"urn:uuid:b84f1d38-eb44-4b2f-83d7-e3bef1da9b97","timestamp":"2022-06-10T11:50:53-04:00","total":6,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1046787","display":"atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML Oral Solution"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1046815","display":"atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1046997","display":"atropine sulfate 0.0582 MG / hyoscyamine sulfate 0.311 MG / phenobarbital 48.6 MG / scopolamine hydrobromide 0.0195 MG Extended Release Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1048124","display":"12 HR atropine sulfate 0.04 MG / chlorpheniramine maleate 8 MG / hyoscyamine sulfate 0.19 MG / pseudoephedrine hydrochloride 90 MG / scopolamine hydrobromide 0.01 MG Extended Release Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"198207","display":"scopolamine 0.4 MG/ML Injectable Solution"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"226552","display":"72 HR scopolamine 0.0139 MG/HR Transdermal System"}]}}